Immune-mediated vincristine-induced neuropathy: Unlocking therapies
- PMID: 33751022
- PMCID: PMC7992412
- DOI: 10.1084/jem.20210286
Immune-mediated vincristine-induced neuropathy: Unlocking therapies
Abstract
Vincristine-induced peripheral neuropathy (VIPN) is a prevalent and painful complication in cancer patients that lacks effective treatments. In this issue of JEM, Starobova et al. (2021. J. Exp. Med.https://doi.org/10.1084/jem.20201452) report that VIPN is driven by innate immune system activation, a discovery that unlocks immunotherapies as potential treatments.
© 2021 Savelieff and Feldman.
Figures
Comment on
-
Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.J Exp Med. 2021 May 3;218(5):e20201452. doi: 10.1084/jem.20201452. J Exp Med. 2021. PMID: 33656514 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
